The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD
Year: 2022
Type: review
Abstract: Inflammatory Bowel Disease (IBD) is characterized by a loss of intestinal barrier function caused by an aberrant interaction between the immune response and the gut microbiota. In IBD, imbalance in cholesterol homeostasis and mitochondrial bioenergetics have been identified as essential events for activating the inflammasome-mediated response. Mitochondrial alterations, such as reduced respiratory complex activities and reduced production of tricarboxylic acid (TCA) cycle intermediates (e.g., citric acid, fumarate, isocitric acid, malate, pyruvate, and succinate) have been described in in vitro and clinical studies. Under inflammatory conditions, mitochondrial architecture in intestinal epithelial cells is dysmorphic, with cristae destruction and high dynamin-related protein 1 (DRP1)-dependent fission. Likewise, these alterations in mitochondrial morphology and bioenergetics promote metabolic shifts towards glycolysis and down-regulation of antioxidant Nuclear erythroid 2-related factor 2 (Nrf2)/Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) signaling. Although the mechanisms underlying the mitochondrial dysfunction during mucosal inflammation are not fully understood at present, metabolic intermediates and cholesterol may act as signals activating the NLRP3 inflammasome in IBD. Notably, dietary phytochemicals exhibit protective effects against cholesterol imbalance and mitochondrial function alterations to maintain gastrointestinal mucosal renewal in vitro and in vivo conditions. Here, we discuss the role of cholesterol and mitochondrial metabolism in IBD, highlighting the therapeutic potential of dietary phytochemicals, restoring intestinal metabolism and function.
Source: Frontiers in Immunology
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: inflammatory bowel disease, cholesterol homeostasis, mitochondrial bioenergetics, NLRP3 inflammasome, mitochondrial dysfunction, TCA cycle intermediates, mitochondrial morphology, glycolysis, intestinal barrier function, gut microbiota, dietary phytochemicals, intestinal epithelial cells, mucosal inflammation
Open Access status: gold
Estimated APC paid: $2,950
Awards: LOSS OF MEMBRANE MICRODOMAIN-CHOLESTEROL HOMEOSTASIS AS DRIVER OF DEFECTIVE INFLAMMASOME SIGNALING AND MITOCHONDRIAL DYSFUNCTION IN INFLAMMATORY BOWEL DISEASES, AVOIDING CHEMOTHERAPY-INDUCED PRO-MIGRATORY PHENOTYPE REWIRING THE MITOCHONDRIAL BIOENERGETICS FOR NEW MIGRASTATICS APPROACHES IN TRIPLE-NEGATIVE BREAST CANCER CELLS., SUPRAMOLECULAR STRUCTURE AND ORGANIZATION OF CRUCIFORM PI-SYSTEMS ON METAL SURFACES. A REFLECTION-ABSORPTION IR AND SURFACE ENHANCED IR SPECTROSCOPY STUDY OF FUTURE PROSPECTS IN MOLECULAR SENSOR DEVICES., G6565020035, G6750385417, REPROGRAMMING MITOCHONDRIAL BIOENERGETIC ADAPTATION WITH ALFA-KETOGLUTARATE AND COENZYME Q10 TO ALLEVIATE INFLAMMATION IN COLITIS-ASSOCIATED MACROPHAGES
OpenAlex ID: W4309463461
